• Log in with Facebook Log in with Twitter Log In with Google      Sign In    
  • Create Account
  LongeCity
              Advocacy & Research for Unlimited Lifespans


Adverts help to support the work of this non-profit organisation. To go ad-free join as a Member.


Photo

Senolytic Therapeutics

senolytics

  • Please log in to reply
No replies to this topic

#1 caliban

  • Admin, Advisor, Director
  • 9,150 posts
  • 581
  • Location:UK

Posted 14 March 2019 - 10:56 PM


http://senolytx.com/

 

Our academic founders have played a key role in demonstrating that senescence occurs in response to cellular damage and that senescence occurs in vivo in normal and pathological settings.

The science is based on our unique ability to design and develop strategies that selectively target and eliminate damaged cells from tissues where they drive disease progression.

Founders have published key academic papers in the field.

 

 

SEN01 - Targeted drug (IPF-Cancer)
The accumulation of Cellular senescence worsens the severity of several fibrotic pathologies. The SEN01 program aims to develop senolytic compounds that target and eliminate senescent cells in fibrotic diseases and certain cancers.
 
SEN02 - Immunotherapy (Oncology)
The discovery program SEN02 is focused on immune system-mediated clearance of damaged cells to improve post-oncological treatment.
 
SEN03 - Discovery platform
We are in the process to discover novel senolytic compounds in collaboration with other companies and research organizations.

 

 

 

A "Life Biosciences" company. 







Also tagged with one or more of these keywords: senolytics

1 user(s) are reading this topic

0 members, 1 guests, 0 anonymous users